Tags

Type your tag names separated by a space and hit enter

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial.

Abstract

Objective

Elderly people with mild cognitive impairment (MCI) are at high risk for dementia. This study compared the effects of standard cognitive training with a creative expression (CrExp) program.

Methods

Adult patients with MCI aged 60 years and older (N=93) were randomly assigned to either CrExp therapy (n=48) or a control group who received standard cognitive training (n=45) for 16 weeks. The Montreal Cognitive Assessment, Chinese Version of the Auditory Verbal Learning Test, Chinese Version of the Category Verbal Fluency Test, Digit Span Test, Trail Making Test, Chinese Version of Activities of Daily Living scale, and Memory Satisfaction Questionnaire were used to measure cognitive functioning and daily living abilities. Assessments were administered at baseline, postintervention, and 6 months follow-up.

Results

At postintervention, patients receiving CrExp therapy scored significantly higher than patients receiving standard cognitive training, in general cognitive functioning, memory, executive function, functional status, and everyday living ability. The improvements in cognitive functioning were maintained at the 6 month follow-up.

Conclusion

CrExp therapy has greater positive effects on cognitive functions and daily living ability than standard cognitive training. This unique therapy may serve as a cost-effective adjunct to standard interventions for older adults with mild cognitive impairment.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    School of Nursing, Fujian Medical University, Fuzhou 350108, People's Republic of China, leehong99@126.com.

    ,

    School of Nursing, Fujian Medical University, Fuzhou 350108, People's Republic of China, leehong99@126.com. Department of Nursing, Fujian Provincial Hospital, Fuzhou 350001, People's Republic of China, leehong99@126.com.

    ,

    School of Nursing, Fujian Medical University, Fuzhou 350108, People's Republic of China, leehong99@126.com.

    ,

    School of Nursing, Fujian Medical University, Fuzhou 350108, People's Republic of China, leehong99@126.com.

    School of Nursing, Fujian Medical University, Fuzhou 350108, People's Republic of China, leehong99@126.com.

    Source

    Clinical interventions in aging 13: 2018 pg 1313-1320

    MeSH

    Activities of Daily Living
    Aged
    Aged, 80 and over
    Alzheimer Disease
    Art Therapy
    Cognition
    Cognitive Dysfunction
    Executive Function
    Female
    Humans
    Male
    Memory

    Pub Type(s)

    Journal Article
    Randomized Controlled Trial

    Language

    eng

    PubMed ID

    30087557

    Citation

    Zhao, Junyu, et al. "Effects of Creative Expression Therapy for Older Adults With Mild Cognitive Impairment at Risk of Alzheimer's Disease: a Randomized Controlled Clinical Trial." Clinical Interventions in Aging, vol. 13, 2018, pp. 1313-1320.
    Zhao J, Li H, Lin R, et al. Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial. Clin Interv Aging. 2018;13:1313-1320.
    Zhao, J., Li, H., Lin, R., Wei, Y., & Yang, A. (2018). Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial. Clinical Interventions in Aging, 13, pp. 1313-1320. doi:10.2147/CIA.S161861.
    Zhao J, et al. Effects of Creative Expression Therapy for Older Adults With Mild Cognitive Impairment at Risk of Alzheimer's Disease: a Randomized Controlled Clinical Trial. Clin Interv Aging. 2018;13:1313-1320. PubMed PMID: 30087557.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer's disease: a randomized controlled clinical trial. AU - Zhao,Junyu, AU - Li,Hong, AU - Lin,Rong, AU - Wei,Yuan, AU - Yang,Aiping, Y1 - 2018/07/24/ PY - 2018/8/9/entrez PY - 2018/8/9/pubmed PY - 2018/11/6/medline KW - cognitive impairment KW - creative expression KW - health care KW - non-pharmaceutical therapy SP - 1313 EP - 1320 JF - Clinical interventions in aging JO - Clin Interv Aging VL - 13 N2 - Objective: Elderly people with mild cognitive impairment (MCI) are at high risk for dementia. This study compared the effects of standard cognitive training with a creative expression (CrExp) program. Methods: Adult patients with MCI aged 60 years and older (N=93) were randomly assigned to either CrExp therapy (n=48) or a control group who received standard cognitive training (n=45) for 16 weeks. The Montreal Cognitive Assessment, Chinese Version of the Auditory Verbal Learning Test, Chinese Version of the Category Verbal Fluency Test, Digit Span Test, Trail Making Test, Chinese Version of Activities of Daily Living scale, and Memory Satisfaction Questionnaire were used to measure cognitive functioning and daily living abilities. Assessments were administered at baseline, postintervention, and 6 months follow-up. Results: At postintervention, patients receiving CrExp therapy scored significantly higher than patients receiving standard cognitive training, in general cognitive functioning, memory, executive function, functional status, and everyday living ability. The improvements in cognitive functioning were maintained at the 6 month follow-up. Conclusion: CrExp therapy has greater positive effects on cognitive functions and daily living ability than standard cognitive training. This unique therapy may serve as a cost-effective adjunct to standard interventions for older adults with mild cognitive impairment. SN - 1178-1998 UR - https://www.unboundmedicine.com/medline/citation/30087557/Effects_of_creative_expression_therapy_for_older_adults_with_mild_cognitive_impairment_at_risk_of_Alzheimer's_disease:_a_randomized_controlled_clinical_trial_ L2 - https://dx.doi.org/10.2147/CIA.S161861 DB - PRIME DP - Unbound Medicine ER -